The non-competitive CYP2E1 inhibitor, clomethiazole, attenuates acute ethanol-induced hepatic steatosis by suppressing oxidative stress, an adiponectin decline, and an activation of autophagy [30]. The gene discussed is CYP2E1; the disease is fatty liver disease.